- Home
- YORW vs THW Comparison
YORW vs THW Comparison
Compare YORW & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | YORW | THW |
|---|---|---|
| Founded | 1816 | N/A |
| Country | United States | United States |
| Employees | 104 | N/A |
| Industry | Water Supply | Finance Companies |
| Sector | Utilities | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.0M | 513.9M |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | YORW | THW |
|---|---|---|
| Price | $30.20 | $11.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 126.0K | 119.6K |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.99% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $77,488,000.00 | N/A |
| Revenue This Year | $11.78 | N/A |
| Revenue Next Year | $4.95 | N/A |
| P/E Ratio | $21.92 | ★ N/A |
| Revenue Growth | ★ 3.37 | N/A |
| 52 Week Low | $29.68 | $9.80 |
| 52 Week High | $36.48 | $13.19 |
Technical Indicators
Market Signals| Indicator | YORW | THW |
|---|---|---|
| Relative Strength Index (RSI) | 35.52 | 29.27 |
| Support Level | $30.02 | $10.18 |
| Resistance Level | $32.98 | $13.11 |
| Average True Range (ATR) | 0.68 | 0.21 |
| MACD | -0.08 | -0.06 |
| Stochastic Oscillator | 20.72 | 0.00 |
Price Performance
Historical ComparisonAbout YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.